T2 Biosystems Inc (TTOO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:T2 Biosystems Inc (TTOO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3412
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company’s products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians’ offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

T2 Biosystems Inc (TTOO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
T2 Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
T2 Biosystems Raises US$40 Million In Series E Financing 11
Partnerships 13
T2 Biosystems Enters into Agreement with Allergan 13
T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 14
Equity Offering 15
T2 Biosystems Raises USD40 Million in Private Placement of Shares 15
T2 Biosystems Raises USD34 Million in Public Offering of Shares 16
T2 Biosystems Raises USD65.7 Million in IPO 18
T2 Biosystems Inc – Key Competitors 20
T2 Biosystems Inc – Key Employees 21
T2 Biosystems Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: T2 Biosystems reports second quarter 2018 financial results and provides corporate update 23
May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 24
Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 25
Nov 02, 2017: T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update 27
Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 29
May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 30
Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 32
Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 34
Corporate Communications 35
May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 35
Government and Public Interest 36
Mar 06, 2018: T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
T2 Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
T2 Biosystems Inc, Deals By Therapy Area, 2012 to YTD 2018 8
T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
T2 Biosystems Raises US$40 Million In Series E Financing 11
T2 Biosystems Enters into Agreement with Allergan 13
T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 14
T2 Biosystems Raises USD40 Million in Private Placement of Shares 15
T2 Biosystems Raises USD34 Million in Public Offering of Shares 16
T2 Biosystems Raises USD65.7 Million in IPO 18
T2 Biosystems Inc, Key Competitors 20
T2 Biosystems Inc, Key Employees 21
T2 Biosystems Inc, Other Locations 22

List of Figures
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
T2 Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
T2 Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[T2 Biosystems Inc (TTOO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Patterson Companies Inc (PDCO):医療機器:M&Aディール及び事業提携情報
    Summary Patterson Companies, Inc. (Patterson) is a distributor of dental and veterinary products, services and technologies. It provides products to the production and companion animal health markets. The company’s product portfolio comprises restorative materials, hand instruments, sterilization pr …
  • Taiwan Semiconductor Manufacturing Company Limited:企業の戦略・SWOT・財務情報
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Gokul Refoils & Solvent Ltd. (GOKUL):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Marsulex Environmental Technologies Corp:企業の戦略的SWOT分析
    Marsulex Environmental Technologies Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Forum Energy Technologies Inc:企業の戦略・SWOT・財務情報
    Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Websol Energy System Ltd (WEBELSOLAR):企業の財務・戦略的SWOT分析
    Summary Websol Energy System Ltd (Websol) is an alternate energy company that offers manufacturing of photovoltaic crystalline solar cells and the related modules. The company offers products such as pv solar cell and pv solar module. Its pv solar cell includes multi crystalline 4bb pv solar cell, m …
  • EP Petroecuador:企業の戦略的SWOT分析
    EP Petroecuador - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Matrai Eromu ZRt:企業の戦略的SWOT分析
    Matrai Eromu ZRt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • China Railway Signal & Communication Corp Ltd:企業の戦略・SWOT・財務情報
    China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Kingsoft Corporation Limited:企業のM&A・事業提携・投資動向
    Kingsoft Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kingsoft Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • PetroChina Co Ltd (857)-石油・ガス分野:企業M&A・提携分析
    Summary PetroChina Company Limited (PetroChina), a subsidiary of China National Petroleum Corporation, is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products …
  • Akebia Therapeutics Inc (AKBA):製薬・医療:M&Aディール及び事業提携情報
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • RWE AG:発電所・企業SWOT分析
    RWE AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Infratil Ltd (IFT):電力:M&Aディール及び事業提携情報
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • PT Pudjiadi Prestige Tbk:企業の戦略・SWOT・財務情報
    PT Pudjiadi Prestige Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Pudjiadi Prestige Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Domain Therapeutics SA-製薬・医療分野:企業M&A・提携分析
    Summary Domain Therapeutics SA (Domain Therapeutics) is a biopharmaceutical company that discovers and develops innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer by using transmembrane and G Protein-Coupled Receptor (GPCR) platform. Its pipeline consists o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆